Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy
about
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesTeratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.Thalidomide: a remarkable comeback.Update on therapy--thalidomide in the treatment of lupus.Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature.Novel therapies in vasculitis.Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.Dermatologic and nondermatologic uses of thalidomide.Managing the symptoms of Behçet's disease.Chemotherapy-induced peripheral neurotoxicity.Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acidAn open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.Update on the Medical Management of Gastrointestinal Behçet's Disease.Update on the therapy of Behçet disease.Preparation and in vitro analysis of microcapsule thalidomide formulation for targeted suppression of TNF-alpha.Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation.New roles for thalidomide.Thalidomide neuropathy: role of F-wave monitoring.Thalidomide revisited: pharmacology and clinical applications.Thalidomide neuropathy in patients treated for metastatic prostate cancer.Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus.Effectiveness and safety of Glycyrrhizae Decoction for Purging Stomach-Fire in Behcet disease patients: Study protocol for a randomized controlled and double-blinding trail.Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.Behçet's diseaseUlcerative Lesions in Behcet's Disease
P2860
Q26799767-C860C2CB-A46A-474F-961F-499E4C601F20Q33753486-1B5438FD-32B2-410F-99D9-12AF197C531DQ34182143-665E7688-5942-458D-9A7F-78A2FD61B868Q34227018-A90C3E91-9D7A-4B8C-B90B-05499B40D719Q34454532-C0F35DE9-01D8-4509-A6F0-0E7272BDD7ECQ34481560-430B50C6-558D-4837-9119-FC6EEB819E10Q35026302-4F808FB1-6D78-4E10-8916-71F26635B3C0Q35201057-1B43508E-1D3D-4F7C-BFD8-0EA97FD3AE9FQ35680592-093373D3-BEDA-442F-8C70-09AEAEBB583FQ35925635-E63B6D9C-CEE9-43DF-85FE-0008DBBB2AB9Q36617691-FC8E6C09-D50F-41F9-A7B6-FBB4C21F594FQ36648834-1E596F82-C472-422F-9E96-D11856D932C9Q37406600-DA77A079-0748-4B55-9C90-B7EB89E12DD6Q37539557-56BD8E2D-F999-4783-AA7A-E2AC8B341E63Q37624811-87020ACB-7D13-42E5-A78F-74232503D301Q37712230-7DC29590-5733-4B95-8147-557F00F97342Q40249947-8E83B534-48F3-47A1-9F99-C9A3D4A5C14CQ41641598-ECF88495-FAFB-4100-AF5C-EF175E51B221Q43189246-2BF3C5D3-75D6-4F05-8FDF-CD8D507DAC4BQ43505621-C468D1C1-D443-4745-892E-B14EC8C4729DQ43596294-7CCE6249-4AB5-47F1-A2CA-86C3CBC42784Q43663434-69026C59-643D-485D-8324-C5C75FE7773CQ44792958-3B7FAECC-FBC2-4758-98C7-64CC742E0F26Q46613737-AD2B19E9-FEDC-4E2A-90FA-03ABDA811E10Q46864452-37A5428C-8BD5-4047-8E47-2FCE7F88853CQ52622848-891C6462-A191-41EC-9DDB-D68B35E7459FQ53705358-B9B31703-1C92-4BBE-9BE1-19FED7FB0FB5Q57213634-E1626F9A-5EA7-4CDB-BCB8-D3B9C74B9F97Q58915176-E0EFB05A-8F3D-47E0-8EC4-CA4788CFCF62
P2860
Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Clinical experience with thali ...... detect thalidomide neuropathy
@ast
Clinical experience with thali ...... detect thalidomide neuropathy
@en
Clinical experience with thali ...... detect thalidomide neuropathy.
@nl
type
label
Clinical experience with thali ...... detect thalidomide neuropathy
@ast
Clinical experience with thali ...... detect thalidomide neuropathy
@en
Clinical experience with thali ...... detect thalidomide neuropathy.
@nl
prefLabel
Clinical experience with thali ...... detect thalidomide neuropathy
@ast
Clinical experience with thali ...... detect thalidomide neuropathy
@en
Clinical experience with thali ...... detect thalidomide neuropathy.
@nl
P2093
P2860
P921
P356
P1476
Clinical experience with thali ...... detect thalidomide neuropathy
@en
P2093
Gardner-Medwin JM
P2860
P304
P356
10.1136/ARD.53.12.828
P407
P577
1994-12-01T00:00:00Z